We are live on ! Find out more
TEE

Tibra Equities Europe Portfolio holdings

AUM $90.4M
1-Year Est. Return 37.81%
This Fund
S&P 500
This Quarter Est. Return
+15.64%
1 Year Est. Return
+37.81%
3 Year Est. Return
+142.96%
5 Year Est. Return
10 Year Est. Return
AUM
$1B
AUM Growth
+$397M
Cap. Flow
+$358M
Cap. Flow %
35.74%
Top 10 Hldgs %
33.39%
Holding
513
New
333
Increased
22
Reduced
19
Closed
139

Sector Composition

Rank Sector Weight
1 Industrials 14.05%
2 Healthcare 12.35%
3 Technology 12.1%
4 Financials 10.01%
5 Consumer Staples 6.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OMER icon
201
Omeros
OMER
$959M
$771K 0.08%
+44,400
New +$640K
MGA icon
202
Magna International
MGA
$18.8B
$769K 0.08%
+15,800
New +$797K
NBEV
203
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$763K 0.08%
+145,089
New +$875K
ETFC
204
DELISTED
E*Trade Financial Corporation
ETFC
$761K 0.08%
16,400
-4,300
-21% -$205K
STR
205
DELISTED
Sitio Royalties
STR
$756K 0.08%
+21,372
New +$699K
XENT
206
DELISTED
Intersect ENT, Inc
XENT
$756K 0.08%
+23,500
New +$727K
XBIT icon
207
XBiotech
XBIT
$69.2M
$750K 0.07%
+68,047
New +$552K
TNDM icon
208
Tandem Diabetes Care
TNDM
$1.56B
$749K 0.07%
+11,800
New +$620K
INSG icon
209
Inseego
INSG
$90.5M
$747K 0.07%
+15,820
New +$808K
MD icon
210
Pediatrix Medical
MD
$2.2B
$744K 0.07%
27,400
+16,000
+140% +$536K
GLW icon
211
Corning
GLW
$143B
$728K 0.07%
22,000
-16,000
-42% -$525K
BT
212
DELISTED
BT Group plc (ADR)
BT
$728K 0.07%
+49,200
New +$737K
KALV
213
DELISTED
KalVista Pharmaceuticals
KALV
$727K 0.07%
+25,401
New +$551K
BDSI
214
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$727K 0.07%
+137,259
New +$627K
HXL icon
215
Hexcel
HXL
$7.82B
$712K 0.07%
+10,300
New +$693K
AMRX icon
216
Amneal Pharmaceuticals
AMRX
$5.79B
$710K 0.07%
+50,100
New +$662K
JWN
217
DELISTED
Nordstrom
JWN
$710K 0.07%
16,000
+500
+3% +$22.8K
KNTK icon
218
Kinetik
KNTK
$7.98B
$704K 0.07%
+11,939
New +$883K
MGLN
219
DELISTED
Magellan Health Services, Inc.
MGLN
$699K 0.07%
+10,600
New +$680K
SWBI icon
220
Smith & Wesson
SWBI
$637M
$697K 0.07%
+97,055
New +$880K
BRKR icon
221
Bruker
BRKR
$8.14B
$696K 0.07%
+18,100
New +$653K
CF icon
222
CF Industries
CF
$17.3B
$687K 0.07%
+16,800
New +$713K
ORI icon
223
Old Republic International
ORI
$10.4B
$686K 0.07%
+32,800
New +$682K
IART icon
224
Integra LifeSciences
IART
$1.34B
$685K 0.07%
+12,300
New +$626K
EIX icon
225
Edison International
EIX
$26.4B
$681K 0.07%
+11,000
New +$656K

Similar funds

Tibra Equities Europe's Q1 2019 Portfolio in Review

As of Q1 2019, Tibra Equities Europe held 513 positions worth $1B, up 65% from $606M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Tibra Equities Europe deployed $358M of net new capital in Q1 2019, opening 333 new positions and adding to 22 existing holdings. Its largest new stake was Union Pacific: 303,100 shares worth $50.7M.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 3.5% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was State Street Energy Select Sector SPDR ETF, an estimated $20.7M trimmed.

  • Tibra Equities Europe's largest Q1 2019 buy was Union Pacific: 303,100 shares worth $50.7M.
  • Tibra Equities Europe added most to State Street Consumer Staples Select Sector SPDR ETF in Q1 2019, an estimated $41.7M increase.
  • Tibra Equities Europe's biggest Q1 2019 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $20.7M.
  • Tibra Equities Europe fully exited iShares MSCI Saudi Arabia ETF in Q1 2019, selling an estimated $66.5M.
  • Tibra Equities Europe's ten largest holdings make up 33% of its $1B portfolio in Q1 2019.
  • Tibra Equities Europe opened 333 new positions and closed 139 in Q1 2019.
  • Tibra Equities Europe's portfolio value rose 65% quarter-over-quarter to $1B.

Based on Tibra Equities Europe's 13F filing for Q1 2019, filed 4 Apr 2019.